3-Year CheckMate743 outcomes: ringing in immunotherapy for the treatment of malignant pleural mesothelioma

Ann Oncol. 2022 May;33(5):457-459. doi: 10.1016/j.annonc.2022.03.004. Epub 2022 Mar 17.

Authors

S Cedres¹, E Felip²

Affiliations

¹ Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
² Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: efelip@vhebron.net.

PMID: 35306158
DOI: 10.1016/j.annonc.2022.03.004

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Immunotherapy
Lung Neoplasms* / pathology
Lung Neoplasms* / therapy
Mesothelioma* / pathology
Mesothelioma* / therapy
Mesothelioma, Malignant*
Pleural Neoplasms* / pathology
Pleural Neoplasms* / therapy